Table 1 General data and intraoperative parameters in patients with or without post-operative complications
No Complications (n = 51) | Complications (n = 39) | p | |
|---|---|---|---|
Age (years) | 72 [63–76] | 70 [65–75] | 0.654 |
Gender (n [% of males]) | 30 [59%] | 29 [74%] | 0.174 |
Comorbidities (n [%]) | |||
Arterial hypertension | 42 [82%] | 27 [69%] | 0.208 |
Dyslipidemia | 19 [37%] | 12 [31%] | 0.655 |
Coronary Artery Disease | 9 [18%] | 12 [31%] | 0.208 |
Diabetes mellitus | 13 [25%] | 6 [15%] | 0.303 |
Chronic cardiac failure | 9 [18%] | 3 [8%] | 0.219 |
Chronic renal failure | 4 [8%] | 8 [20%] | 0.117 |
Chronic Obstructive Pulmonary Disease | 5 [10%] | 4 [10%] | 0.999 |
Duration of ECC (min) | 126 [96–167] | 116 [81–166] | 0.523 |
Duration of clamping (min) | 100 [68–126] | 95 [60–129] | 0.631 |
Worst parameters during ECC | |||
Min MAP (mmHg) | 60 [50–65] | 55 [50–61] | 0.158 |
Min haematocrit (%) | 25 [22–28] | 24 [21–27] | 0.771 |
Min haemoglobin (g/dL) | 8.0 [7.0–8.8] | 7.9 [6.8–9.0] | 0.924 |
Min SvO2 (%) | 82 [80–86] | 81 [78–84] | 0.227 |
Max lactate (mmol/L) | 2.2 [1.5–3.1] | 2.4 [1.9–3.3] | 0.337 |
Max blood glucose (mg/dL) | 168 [136–186] | 156 [137–192] | 0.918 |